Naoya Sakamoto

Also affiliated with National Cancer Center Hospital East

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies”.

Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies

Nature Communications(2025)10.1038/s41467-025-65148-6

N/A

0.472DataRank · unranked

15 citations

Keiko Takahashi, Naoya Sakamoto, Martina De Vizio, Micaela Morgado, Shahryar Khoshtinat Nikkhoi +17 more

Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin(2020)10.1007/s00428-020-02840-6

N/A

0DataRank · unranked

54 citations

Naoya Sakamoto, Junko Murai, Daiki Taniyama, Ririno Honma, Shoichi Ukai +6 more

Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers

British Journal of Cancer(2021)10.1038/s41416-021-01364-3

N/A

0DataRank · unranked

53 citations

Daiki Taniyama, Naoya Sakamoto, Maika Yasumoto, Ryuichi Asai, Takuya Hattori +13 more